Tsumura & Co
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines, as well as Kampo po… Read more
Tsumura & Co - Asset Resilience Ratio
Tsumura & Co (TSUA) has an Asset Resilience Ratio of 0.14% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2018)
This chart shows how Tsumura & Co's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Tsumura & Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €706.00 Million | 0.14% |
| Total Liquid Assets | €706.00 Million | 0.14% |
Asset Resilience Insights
- Limited Liquidity: Tsumura & Co maintains only 0.14% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tsumura & Co Industry Peers by Asset Resilience Ratio
Compare Tsumura & Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Lavipharm S.A
AT:LAVI |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Medicon Hellas S.A.
AT:MEDIC |
Drug Manufacturers - Specialty & Generic | 32.11% |
Annual Asset Resilience Ratio for Tsumura & Co (2018–2018)
The table below shows the annual Asset Resilience Ratio data for Tsumura & Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-03-31 | 1.19% | €3.50 Billion | €293.70 Billion | -- |